Navigation Links
AEGON and Right To Play Announce Global Partnership
Date:7/3/2008

THE HAGUE, The Netherlands, July 4 /PRNewswire-FirstCall/ -- AEGON N.V. and the international humanitarian organization Right To Play announce a new global partnership to extend the organization's mission to help children in deprived areas of Sudan, Uganda, Ghana and China. AEGON N.V. has donated EUR 1 million as part of a three year partnership that will extend through the 2010 Winter Olympic games in Vancouver, Canada.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080704/311773 )

Right To Play, founded by four-time Olympic Gold medalist and current CEO Johann Olav Koss, uses sport and play programs to improve health, develop life skills, and foster peace for children and communities in some of the most disadvantaged areas of the world. Currently, Right To Play has projects in over twenty countries in Africa, Asia and the Middle East. Its programs target the most vulnerable, including young girls, the disabled, children affected by HIV and AIDS, street children, former child combatants and refugees.

"AEGON is honored to join with Right To Play in improving the lives of children who are forced to endure some of the most desperate circumstances around the world," said AEGON CEO Alexander Wynaendts. "We are committed to making a difference in the communities where we work and live, and also in places where we may not necessarily be active in business but where we can still help to create better futures through respected and effective organizations such as Right To Play."

Right To Play was built in the 1990s on the power and values of sport, demonstrated by the engagement of Athlete Ambassadors from more than 40 countries who serve as positive role models and advocates for children. AEGON has long sponsored high-achieving athletes to support athletic excellence and reinforce the value it places on teamwork, communication, respect and trust. The relationshi
'/>"/>

SOURCE AEGON N.V.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Renowned Iowa Orthopaedic Surgeon, John Albright, MD, Inducted into Sports Medicine Hall of Fame
2. World's First USB Duplicator with Copy Protection and Digital Rights Management Available from Nexcopy and TrusCont Ltd.
3. SleepRight(R) Dental Guard Receives FDA Clearance
4. Young Man With Severe Disabilities Wins Right to Services From State Enabling Him to Live At Home
5. New York Legislators Kill Bill for Grieving Mothers. Womens Rights Activist stands up for some women and not others.
6. American Right to Life Endorses U.S. Senator Roger Wickers Life at Conception Act
7. May 2008 issue on conflict and crisis settings: Promoting sexual and reproductive rights
8. China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products
9. Professor Chon Abraham of the Mason School of Business at The College of William & Mary named Fulbright Scholar
10. Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
11. Duke chemist has new way to tell right from left
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... March 28, 2015 The "Petrick ... of sustainable health. After 18 years of research and ... professional UFC contenders, Dr. Jon Petrick is excited to ... Just some of the immediate benefits of this radical ... increased levels of strength of the immune system, faster ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... In her mid-forties and with a lifelong ... Monica K. arrived at JET Uniform & Supply ... and scared. The owners and staff at JET, which had ... to offer jobs to challenged residents like Monica, were patient. ... to begin with the end in mind,” says Stephen Milaney, ...
(Date:3/27/2015)... Kansas City, Mo (PRWEB) March 27, 2015 ... common complications for patients undergoing percutaneous coronary intervention ... Ironically, studies have observed a “risk-treatment paradox,” in ... to gain from treatment are treated less often ... , Researchers at Saint Luke’s Mid America Heart ...
(Date:3/27/2015)... 27, 2015 Ticket Down is a reputable source ... 2015. After a phenomenal and highly successful live tour last ... going out on tour again in 2015 and they will be ... on April 29th in New York City at the cozy Beacon ... Theatre on May 10th. , Fans of the hit show can ...
Breaking Medicine News(10 mins):Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2
... Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical ... for the treatment of human viral,and other infectious ... quarter and year ended December 31, 2007. At ... securities totaled,$112.0 million., Significant ...
... March 6, 2008 A study released this ... Healthcare System in California shows that non-polypoid colorectal neoplasms ... than previously thought and may have a greater association ... commonly diagnosed colorectal polyp. The study appears in the ...
... of nursing would,help address the severe nurse faculty ... WASHINGTON, March 6 Today, the American,Association ... Durbin,(D-IL) for introducing the Troops to Nurse Teachers ... when the military and civilian healthcare systems have,been ...
... A study released,this week from researchers at ... shows that non-polypoid colorectal neoplasms or flat,colon lesions, ... and may,have a greater association with cancer compared ... polyp. The study appears in the,March 5 issue ...
... DALLAS, March 6 State Medicaid programs ... innovative,initiative of Affiliated Computer Services, Inc. (NYSE: ... ACS, healthcare clients avoid costly,manual recovery of drug ... enables pharmacies to immediately identify pharmacy,benefit coverage at ...
... offers hope of new diabetes treatments , , THURSDAY, ... levels disable the molecular switch that normally turns off ... insulin levels, a California study finds. , This ... the "sugar-off" switch (CRTC2) may help lower glucose levels ...
Cached Medicine News:Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 2Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 3Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 4Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 5Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 6Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 7Health News:Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results 8Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 2Health News:AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 3Health News:Colonoscopy Used to Identify and Remove Flat Colon Lesions: Flat Colon Lesions More Common and More Likely to Be Cancer According to JAMA Study 2Health News:Colonoscopy Used to Identify and Remove Flat Colon Lesions: Flat Colon Lesions More Common and More Likely to Be Cancer According to JAMA Study 3Health News:Colonoscopy Used to Identify and Remove Flat Colon Lesions: Flat Colon Lesions More Common and More Likely to Be Cancer According to JAMA Study 4Health News:ACS Launches Medicaid Cost Savings Initiative 2Health News:ACS Launches Medicaid Cost Savings Initiative 3Health News:Constant High Blood Sugar Disables Insulin 'Off' Switch 2
(Date:3/27/2015)... March 27, 2015  RXi Pharmaceuticals Corporation ... LLC, today announced that they have entered ... novel and proprietary sd-rxRNA® technology for use ... collaboration has the potential to result in ... treatments that could be a significant step ...
(Date:3/27/2015)... , March 27, 2015  WebMD ... leading source of health information, today announced ... new National Action Plan for Combating ... Obama emphasized the urgency and importance of ... national and global health.    The ...
(Date:3/26/2015)... March 26, 2015  OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... clinical developments and announced fourth quarter and year ... Developments and Anticipated Near-term MilestonesCustirsen , ... to negotiate the termination of their collaboration and ... final termination agreement are ongoing. , Two ...
Breaking Medicine Technology:RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
... HAMILTON, Bermuda , April 30 Celtic Pharmaceutical Holdings L.P. ... pharmaceutical industries, announced today the enrolment of the first patient into its ... treatment of onychomycosis (also known as a fungal nail infection).   , ... This Phase III trial is ...
... , April 29 Abraxis BioScience initially ... the former ICN/Valient Pharmaceutical building in Costa Mesa, ... foot building. The "due diligence report" revealed an array ... occupying the building, and once the building purchase was ...
Cached Medicine Technology:Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis 2Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis 3Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis 4LCS Constructors, Inc. Completes First Major Phase of Abraxis BioScience Project 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: